Review outlines diagnostic and therapeutic strategies for feline mammary carcinomas, highlighting the need for standardized staging and risk-adapted treatment pathways.
Feline mammary carcinomas remain a major therapeutic and prognostic challenge in veterinary oncology because they combine high malignant potential, early dissemination, and substantial heterogeneity in clinicopathologic behaviour. This review summarizes current clinical knowledge on epidemiology, risk factors, diagnostic work-up, staging, treatment, and prognostic assessment of feline mammary carcinomas, highlighting areas of consensus and persistent controversies. Progress in care will require prospective, multicentre studies built on harmonized staging and pathology reporting, enabling risk-adapted treatment pathways that are both evidence-based and clinically actionable.
No takes yet. Share an insight, caveat, or question.
Petrucci et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: